Catalyst Wire Dossier Catalyst Wire Dossier

Bmab 1000

· Biocon Biologics UK Ltd
Drug timelines are a Plus or Pro feature.

1 regulatory and trial event tracked for Bmab 1000, covering 2025-08-19 to 2025-08-19. Get the full timeline:

Most recent: Clinical Trial Update: Comparison of Efficacy, Pharmacodynamics, Safety, and Immunogenicity Between Bmab 1000 and Prolia® in Postmenopausal Women With Osteoporosis [Phase 3]

See pricing